Age, drugs, or disease: What alters the macrostructure of sleep in Parkinson's disease?

Sleep Medicine

Volumn 13, Issue 9, 2012, Pages 1178-1183

  Sixel Döring, Friederike ^a   Trautmann, Ellen ^a   Mollenhauer, Brit ^a   Trenkwalder, Claudia ^a  

^a Paracelsus Elena Klinik   (Germany)

Author keywords

Dopamine agonists; Parkinson's disease; PLMS; Polysomnography; RBD; Sleep

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; OPIATE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR;

AGE; AGED; ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; RISK ASSESSMENT; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP QUALITY; SLEEP STAGE;

AGE FACTORS; AGED; ANTIPARKINSON AGENTS; FEMALE; HUMANS; MALE; NOCTURNAL MYOCLONUS SYNDROME; PARKINSON DISEASE; POLYSOMNOGRAPHY; REM SLEEP BEHAVIOR DISORDER; SLEEP; SLEEP DISORDERS; SLEEP STAGES;

EID: 84867461157     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.06.009     Document Type: Article

References (43)

1. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988, 11:512-519.
2. Oerlemans W.G., de Weerd A.W. The prevalence of sleep disorders in patients with Parkinson's disease. A self-reported, community-based survey. Sleep Med 2002, 3:147-149.
3. Tandberg E., Larsen J.P., Karlsen K. A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 1998, 13:895-899.
4. Chaudhuri K.R., Yates L., Martinez-Martin P. The non-motor symptom complex of Parkinson's disease: a comprehensive assessment is essential. Curr Neurol Neurosci Rep 2005, 5:275-283.
5. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
6. Rye D.B., Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 2002, 58:341-346.
7. Mehta S.H., Morgan J.C., Sethi K.D. Sleep disorders associated with Parkinson's disease: role of dopamine, epidemiology, and clinical scales of assessment. CNS Spectr 2008, 13:6-11.
8. Factor S.A., McAlarney T., Sanchez-Ramos J.R., Weiner W.J. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990, 5:280-285.
9. Hogl B.E., Gomez-Arevalo G., Garcia S., et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology 1998, 50:1332-1339.
10. Wetter T.C., Collado-Seidel V., Pollmacher T., Yassouridis A., Trenkwalder C. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000, 23:361-367.
11. Chokroverty S. Sleep and degenerative neurologic disorders. Neurol Clin 1996, 14:807-826.
12. Diederich N.J., Vaillant M., Mancuso G., Lyen P., Tiete J. Progressive sleep 'destructuring' in Parkinson's disease. A polysomnographic study in 46 patients. Sleep Med 2005, 6:313-318.
13. Kales A., Ansel R.D., Markham C.H., Scharf M.B., Tan T.L. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971, 12:397-406.
14. Brunner H., Wetter T.C., Hogl B., Yassouridis A., Trenkwalder C., Friess E. Microstructure of the non-rapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: effects of dopaminergic treatment. Mov Disord 2002, 17:928-933.
15. Cianchetti C., Masala C., Mangoni A., Gessa G.L. Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect. Psychopharmacology (Berl) 1980, 67:61-65.
16. Tan A., Salgado M., Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996, 11:214-216.
17. Diederich N.J., Paolini V., Vaillant M. Slow wave sleep and dopaminergic treatment in Parkinson's disease: a polysomnographic study. Acta Neurol Scand 2009, 120:308-313.
18. Wailke S., Herzog J., Witt K., Deuschl G., Volkmann J. Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease. Eur J Neurol 2011, 18:590-596.
19. Sixel-Doring F., Trautmann E., Mollenhauer B., Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology 2011, 77:1048-1054.
20. Eggert K., Oertel W., Reichmann H., et al. Leitlinie Parkinson-Syndrome: Diagnostik und Therapie. und die Kommission Leitlinien der Deutschen Gesellschaft für Neurologie (Hrsg.). Leitlinien für Diagnostik und Therapie in der Neurologie 2008, 82-112. Georg Thieme Verlag, Stuttgart. H.C. Diener, N. Putzki (Eds.).
21. Chaudhuri K.R., Pal S., DiMarco A., et al. The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 73:629-635.
22. Trenkwalder C., Kohnen R., Hogl B., et al. Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord 2011, 26:644-652.
23. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4:101-119.
24. Ohayon M.M., Carskadon M.A., Guilleminault C., Vitiello M.V. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004, 27:1255-1273.
25. Redline S., Kirchner H.L., Quan S.F., Gottlieb D.J., Kapur V., Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing on sleep architecture. Arch Intern Med 2004, 164:406-418.
26. Hogl B., Rothdach A., Wetter T.C., Trenkwalder C. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003, 28:1866-1870.
27. Yong M.H., Fook-Chong S., Pavanni R., Lim L.L., Tan E.K. Case control polysomnographic studies of sleep disorders in Parkinson's disease. PLoS One 2011, 6:e22511.
28. Monaca C., Duhamel A., Jacquesson J.M., et al. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med 2006, 7:448-453.
29. De Cock V.C., Lannuzel A., Verhaeghe S., et al. REM sleep behavior disorder in patients with guadeloupean Parkinsonism, a tauopathy. Sleep 2007, 30:1026-1032.
30. Sixel-Doring F., Schweitzer M., Mollenhauer B., Trenkwalder C. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy. Sleep Med 2009, 10:407-415.
31. Gehrman P., Stepnowsky C., Cohen-Zion M., Marler M., Kripke D.F., Ancoli-Israel S. Long-term follow-up of periodic limb movements in sleep in older adults. Sleep 2002, 25:340-343.
32. Bliwise D.L., Trotti L.M., Yesavage J.A., Rye D.B. Periodic leg movements in sleep in elderly patients with Parkinsonism and Alzheimer's disease. Eur J Neurol 2012, 19:918-923.
33. Happe S., Pirker W., Klosch G., Sauter C., Zeitlhofer J. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. J Neurol 2003, 250:83-86.
34. Ferri R., Zucconi M., Manconi M., Plazzi G., Bruni O., Ferini-Strambi L. New approaches to the study of periodic leg movements during sleep in restless legs syndrome. Sleep 2006, 29:759-769.
35. Cochen De Cock V., Abouda M., Leu S., et al. Is obstructive sleep apnea a problem in Parkinson's disease. Sleep Med 2010, 11:247-252.
36. Verbaan D., van Rooden S.M., van Hilten J.J., Rijsman R.M. Prevalence and clinical profile of restless legs syndrome in Parkinson's disease. Mov Disord 2010, 25:2142-2147.
37. Moller J.C., Unger M., Stiasny K., Oertel W.H. Restless legs syndrome (RLS) and Parkinson's disease (PD)-related disorders or different entities?. J Neurol Sci 2010, 289:135-137.
38. Tagaya H., Wetter T.C., Winkelmann J., et al. Pergolide restores sleep maintenance but impairs sleep EEG synchronization in patients with restless legs syndrome. Sleep Med 2002, 3:49-54.
39. Cavas M., Navarro J.F. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:668-678.
40. Lagos P., Scorza C., Monti J.M., et al. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats. Eur Neuropsychopharmacol 1998, 8:113-120.
41. Monti J.M., Hawkins M., Jantos H., D'Angelo L., Fernandez M. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology (Berl) 1988, 95:395-400.
42. Trampus M., Ferri N., Adami M., Ongini E. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 1993, 235:83-87.
43. Trenkwalder C., Kies B., Rudzinska M., et al. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011, 26:90-99.